Skip to content
OpenCapital
Get started

Franklin Covey FC Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

FTI Consulting logo
FTI ConsultingFCN
——

Other financials

Income statement

See full
Revenue$59.6M+0.1%
Gross profit$45.3M-1.0%
Operating income-$2.0M-37.4%
Net income-$2.0M-84.2%
EPS (diluted)-$0.17-113%

Balance sheet

See full
Cash & equivalents$13.7M-66.0%
Total debt$7.0M-14.0%
Total equity$38.1M-47.5%
Total assets$206.5M-6.7%

Cash flow

See full
Operating cash flow$16.3M—
CapEx$1.0M-18.6%
Free cash flow$15.2M—

Valuation

See full
Market cap$276.51M-18.9%
P/S1.1×-0.2×

Profitability

See full
Gross margin75.8%-1.2pp
Operating margin0%-9.2pp
Net margin-0.9%-7.1pp
FCF margin9.1%—

Returns & leverage

See full
Return on equity-4.2%-29.0pp
Debt / equity0.1×0.0×
Current ratio0.6×-0.3×

Where this comes from

Reported directly by Franklin Covey in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: Franklin Covey’s 10-K, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Franklin Covey's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Franklin Covey's indefinite-lived research and development assets?
Franklin Covey (FC) reported indefinite-lived research and development assets of $2.95M in Q2 2025.
What is the long-term trend for Franklin Covey's indefinite-lived research and development assets?
Over 2 years (2023 to 2025), Franklin Covey's indefinite-lived research and development assets has grown at a 54.6% compound annual growth rate (CAGR), from $1.24M to $2.95M.
What does indefinite-lived research and development assets mean?
These are acquired in-process research and development assets that do not have a finite useful life and are therefore not subject to periodic amortization. They represent the value of ongoing innovation projects that have not yet reached commercial viability. Changes in this balance reflect the company's investment in long-term intellectual property and future product pipelines.